DEXLANSOPRAZOLE

Generic: DEXLANSOPRAZOLE

Mylan Pharmaceuticals Inc.Manufacturer
ORALRoute
DEXLANSOPRAZOLE SESQUIHYDRATEActive Substance
2024-01-19Original Approval

DEXLANSOPRAZOLE is FDA application ANDA205205, sponsored by MYLAN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
365 reports
2
CHRONIC KIDNEY DISEASE
334 reports
3
NAUSEA
290 reports
4
DEATH
256 reports
5
OFF LABEL USE
253 reports
6
FATIGUE
249 reports
7
DYSPNOEA
246 reports
8
ACUTE KIDNEY INJURY
215 reports
9
VOMITING
205 reports
10
PAIN
199 reports